HeartSciences Inc. (HSCSW) stock
HSCSWNasdaqFinance ServicesFiscal year ends April 30Also trades as HSCS
$0.07−0.03 (-30.62%)
Close on Oct 30, 2026Market cap $15.89MP/E –Yield 0.00%
HeartSciences gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
HeartSciences's gross profit for the twelve months ending Jul 31, 2026 was $2.75K. For fiscal 2026 it was $2.55K, up 3.3% from the year before. The highest annual figure on record is $12.52K in fiscal 2024.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 30, 2026 | $2.55K | +3.3% |
| FY2025 | Apr 30, 2025 | $2.47K | -80.3% |
| FY2024 | Apr 30, 2024 | $12.52K | +431.8% |
| FY2023 | Apr 30, 2023 | $2.35K | -63.7% |
| FY2022 | Apr 30, 2022 | $6.48K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027 | Jul 31, 2026 | $1.34K | +17.5% |
| Q4 FY2026 | Apr 30, 2026 | $0 | -100.0% |
| Q3 FY2026 | Jan 31, 2026 | $0 | – |
| Q2 FY2026 | Oct 31, 2025 | $1.41K | – |
| Q1 FY2026 | Jul 31, 2025 | $1.14K | -88.8% |
| Q4 FY2025 | Apr 30, 2025 | $2.47K | +3.8% |
| Q3 FY2025 | Jan 31, 2025 | $0 | – |
| Q4 FY2024 | Apr 30, 2024 | $0 | -100.0% |
| Q3 FY2024 | Jan 31, 2024 | $10.14K | – |
| Q2 FY2024 | Oct 31, 2023 | $2.38K | +104.5% |
| Q4 FY2023 | Apr 30, 2023 | $0 | -100.0% |
| Q3 FY2023 | Jan 31, 2023 | $1.19K | -36.9% |
| Q2 FY2023 | Oct 31, 2022 | $0 | – |
| Q1 FY2023 | Jul 31, 2022 | $1.16K | -32.6% |
| Q4 FY2022 | Apr 30, 2022 | $2.87K | – |
| Q3 FY2022 | Jan 31, 2022 | $1.89K | – |
| Q2 FY2022 | Oct 31, 2021 | $0 | – |
| Q1 FY2022 | Jul 31, 2021 | $1.73K | – |